UBE2D3-GSTCD Fusion FISH Probe
The UBE2D3-GSTCD Fusion FISH Probe is used to confirm a fusion of the UBE2D3 and GSTCD genes. The fusion of the UBE2D3 and GSTCD genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| UBE2D3-GSTCD-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-RERE | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-REOR | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-REGO | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-REGR | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-OROR | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GORE | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GROR | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| UBE2D3-GSTCD-20-AQAQ | 20 (40 μL) | 200 μL |
|
UBE2D3 Gene Summary
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme functions in the ubiquitination of the tumor-suppressor protein p53, which is induced by an E3 ubiquitin-protein ligase. [provided by RefSeq, Jan 2017]
Gene Name: Ubiquitin Conjugating Enzyme E2 D3
Chromosome: CHR4: 103717132 -103790032
Locus: 4q24
GSTCD Gene Summary
The Glutathione S-transferase C-terminal Domain Containing (GSTCD) gene is located on chr4 :106629940-106768882 at 4q24.
Gene Name: Glutathione S-transferase C-terminal Domain Containing
Chromosome: CHR4: 106629940 -106768882
Locus: 4q24
Gene Diseases
The UBE2D3 GSTCD Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|